GET THE APP

Journal of Leukemia

ISSN - 2329-6917

+44 1300 500008

Mast Cell Leukemia

Mast cell leukemia (MCL) is a very rare form of aggressive systemic mastocytosis accounting for < 1% of all mastocytosis. It may appear de novo or secondary to previous mastocytosis and shares more clinicopathologic aspects with systemic mastocytosis than with acute myeloid leukemia. Symptoms of mast cell activation-involvement of the liver, spleen, peritoneum, bones, and marrow-are frequent.

The common phenotypic features of pathologic mast cells encountered in most forms of mastocytosis are unreliable in MCL.

Related Journals of Mast Cell Leukemia

Journal of Leukemia, Cancer Surgery, Advances in Cancer Prevention, Chemotherapy: Open Access, Cell Science & Therapy, Leukemia & Lymphoma, Hematological Oncology, Medical and Pediatric Oncology, Seminars in Radiation Oncology, Cancer Treatment Reviews, Cancer Science, Cancer Causes & Control
Top